EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

RNaseH2 mutants that cause Aicardi-Goutieres syndrome are active nucleases



RNaseH2 mutants that cause Aicardi-Goutieres syndrome are active nucleases



Journal of Molecular Medicine 87(1): 25-30



Mutations in the genes encoding the RNaseH2 and TREX1 nucleases have been identified in patients with Aicardi-Goutieres syndrome (AGS). To determine if the AGS RNaseH2 mutations result in the loss of nuclease activity, the human wild-type RNaseH2 and four mutant complexes that constitute the majority of mutations identified in AGS patients have been prepared and tested for ribonuclease H activity. The heterotrimeric structures of the mutant RNaseH2 complexes are intact. Furthermore, the ribonuclease H activities of the mutant complexes are indistinguishable from the wild-type enzyme with the exception of the RNaseH2 subunit A (Gly37Ser) mutant, which exhibits some evidence of altered nuclease specificity. These data indicate that the mechanism of RNaseH2 dysfunction in AGS cannot be simply explained by loss of ribonuclease H activity and points to a more complex mechanism perhaps mediated through altered interactions with as yet identified nucleic acids or protein partners.

(PDF same-day service: $19.90)

Accession: 055338031

Download citation: RISBibTeXText

PMID: 19034401

DOI: 10.1007/s00109-008-0422-3



Related references

Late diagnosis and atypical brain imaging of Aicardi-Goutières syndrome: are we failing to diagnose Aicardi-Goutières syndrome-2?. Developmental Medicine and Child Neurology 59(12): 1307-1311, 2017

Astrocytes, an active player in Aicardi-Goutières syndrome. Brain Pathology 28(3): 399-407, 2018

Aicardi-Goutières Syndrome. Indian Journal of Pediatrics 83(8): 882-883, 2016

Aicardi-Goutières syndrome. Brain & Development 27(3): 201-206, 2005

Aicardi-Goutieres syndrome. British Medical Bulletin 89: 183-201, 2009

Aicardi-Goutières syndrome. Handbook of Clinical Neurology 113: 1629-1635, 2014

The aicardi-goutieres syndrome. Molecular and Chemical Neuropathology 27(1): 47-49, 1996

Aicardi-Goutières syndrome (AGS). European Journal of Paediatric Neurology 12(5): 355-358, 2008

Aicardi-Goutieres syndrome in siblings. Journal of Child Neurology 16(10): 759-761, 2001

Therapies in aicardi-goutieres syndrome. 2013

Two siblings with a new Aicardi-Goutieres-like syndrome. Developmental Medicine & Child Neurology 44(6): 422-425, June, 2002

The genetics of Aicardi-Goutières syndrome. European Journal of Paediatric Neurology 6 Suppl A: A33-5; Discussion A37-9, A77-86, 2002

Interferon and Aicardi-Goutières syndrome. European Journal of Paediatric Neurology 6 Suppl A: A47-53; Discussion A55-8, A77-86, 2002

Characterisation of Aicardi-Goutières syndrome. Lancet. Neurology 12(12): 1131-1132, 2014

Therapies in Aicardi-Goutières syndrome. Clinical and Experimental Immunology 175(1): 1-8, 2014